相关实验视频

Updated: Sep 14, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

设计用于抗结核剂的新 InhA 抑制剂,使用 ab Initio 碎片分子轨道计算

Thimpika Pornprom¹, Bongkochawan Pakamwong¹, Darunee Sukchit¹

¹Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.

|July 21, 2025

概括

这项研究通过模拟它们与InhA酶的相互作用来设计新型的西米达衍生物作为潜在的结核病治疗方法. 确定了关键的电子相互作用,以增强药物结合 afinity 改善化疗.

科学领域:

生物化学生物化学
药用化学医学化学
计算化学计算化学

背景情况:

结核病仍然是全球主要的死亡原因.
InhA酶对于菌根细菌细胞壁生物合成至关重要,也是抗结核药物的关键标.

研究的目的:

设计和识别具有与InhA酶高结合亲和度的新型本齐米达衍生物.
为了阐明关键的电子相互作用,以改善InhA抑制.

主要方法:

合理设计和虚拟选24种胺衍生物.
使用ab initio碎片分子轨道 (FMO) 计算来模拟相互作用.
在化合物选择中应用了利宾斯基的五项规则和毒性预测.

主要成果:

确定了九种有前途的西米达衍生物作为潜在的InhA抑制剂.
突出了抑制剂和InhA残留物 (Gln100,Ala157,Ile215) 和尼古丁胺胺氨基二核酸之间的特定键相互作用.
证实了战略替代剂修饰在增强结合亲和力方面的作用.

结论:

这项研究为设计有效的InhA抑制剂提供了有价值的结构见解.
首先,分子模拟对于推进结核病化疗药物设计至关重要.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...